Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1995 Jun;146(6):1388–1396.

Widespread cytoskeletal pathology characterizes corticobasal degeneration.

M B Feany 1, D W Dickson 1
PMCID: PMC1870913  PMID: 7778678

Abstract

Corticobasal degeneration (CBD) is a rare, progressive neurological disorder characterized by widespread neuronal and glial pathology. Using immunohistochemistry and laser confocal microscopy, we demonstrate that the nonamyloid cortical plaques of CBD are actually collections of abnormal tau in the distal processes of astrocytes. These glial cells express both vimentin and CD44, markers of astrocyte activation. Glial pathology also includes tau-positive cytoplasmic inclusions, here localized to Leu 7-expressing oligodendrocytes. In addition, a wide array of neuronal pathology is defined with tau-positive inclusions in multiple domains of a variety of cortical neurons. CBD thus exhibits widespread glial and neuronal cytoskeletal pathology, including a novel structure, the astrocytic plaque. CBD is a disease of generalized cytoskeletal disruption affecting several cell types and multiple domains of these cells. The further definition of CBD pathology refines the diagnosis and pathophysiological understanding of this unique disease and has important implications for other neurodegenerative diseases, like Alzheimer's disease, characterized by abnormal tau deposition.

Full text

PDF
1388

Images in this article

1390Figure 1
on p.1390
1391Figure 2
on p.1391
1392Figure 3
on p.1392
1393Figure 4
on p.1393

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe H., Yagishita S., Amano N., Iwabuchi K., Hasegawa K., Kowa K. Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: immunocytochemical and ultrastructural study. Acta Neuropathol. 1992;84(3):273–277. doi: 10.1007/BF00227820. [DOI] [PubMed] [Google Scholar]
  2. Arima K., Murayama S., Mukoyama M., Inose T. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions. Acta Neuropathol. 1992;83(5):453–460. doi: 10.1007/BF00310020. [DOI] [PubMed] [Google Scholar]
  3. Biernat J., Mandelkow E. M., Schröter C., Lichtenberg-Kraag B., Steiner B., Berling B., Meyer H., Mercken M., Vandermeeren A., Goedert M. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 1992 Apr;11(4):1593–1597. doi: 10.1002/j.1460-2075.1992.tb05204.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bignami A., Hosley M., Dahl D. Hyaluronic acid and hyaluronic acid-binding proteins in brain extracellular matrix. Anat Embryol (Berl) 1993 Nov;188(5):419–433. doi: 10.1007/BF00190136. [DOI] [PubMed] [Google Scholar]
  5. Braak H., Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol. 1989 Jan-Feb;15(1):13–26. doi: 10.1111/j.1365-2990.1989.tb01146.x. [DOI] [PubMed] [Google Scholar]
  6. Carpenter A. F., Carpenter P. W., Markesbery W. R. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol. 1993 Nov;52(6):601–608. doi: 10.1097/00005072-199311000-00007. [DOI] [PubMed] [Google Scholar]
  7. Couchie D., Charrière-Bertrand C., Nunez J. Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells. J Neurochem. 1988 Jun;50(6):1894–1899. doi: 10.1111/j.1471-4159.1988.tb02494.x. [DOI] [PubMed] [Google Scholar]
  8. Dickson D. W., Crystal H., Mattiace L. A., Kress Y., Schwagerl A., Ksiezak-Reding H., Davies P., Yen S. H. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol. 1989;78(6):572–584. doi: 10.1007/BF00691284. [DOI] [PubMed] [Google Scholar]
  9. Dickson D. W., Ksiezak-Reding H., Liu W. K., Davies P., Crowe A., Yen S. H. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site. Acta Neuropathol. 1992;84(6):596–605. doi: 10.1007/BF00227736. [DOI] [PubMed] [Google Scholar]
  10. Dickson D. W., Yen S. H., Suzuki K. I., Davies P., Garcia J. H., Hirano A. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol. 1986;71(3-4):216–223. doi: 10.1007/BF00688042. [DOI] [PubMed] [Google Scholar]
  11. Gibb W. R., Luthert P. J., Marsden C. D. Corticobasal degeneration. Brain. 1989 Oct;112(Pt 5):1171–1192. doi: 10.1093/brain/112.5.1171. [DOI] [PubMed] [Google Scholar]
  12. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 1993 Nov;16(11):460–465. doi: 10.1016/0166-2236(93)90078-z. [DOI] [PubMed] [Google Scholar]
  13. Greenberg S. G., Davies P. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5827–5831. doi: 10.1073/pnas.87.15.5827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hof P. R., Morrison J. H. Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp Neurol. 1991 Mar;111(3):293–301. doi: 10.1016/0014-4886(91)90096-u. [DOI] [PubMed] [Google Scholar]
  15. Iwatsubo T., Hasegawa M., Ihara Y. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics. Acta Neuropathol. 1994;88(2):129–136. doi: 10.1007/BF00294505. [DOI] [PubMed] [Google Scholar]
  16. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch Neurol. 1985 Nov;42(11):1097–1105. doi: 10.1001/archneur.1985.04060100083029. [DOI] [PubMed] [Google Scholar]
  17. Kosik K. S., Crandall J. E., Mufson E. J., Neve R. L. Tau in situ hybridization in normal and Alzheimer brain: localization in the somatodendritic compartment. Ann Neurol. 1989 Sep;26(3):352–361. doi: 10.1002/ana.410260308. [DOI] [PubMed] [Google Scholar]
  18. Ksiezak-Reding H., Chien C. H., Lee V. M., Yen S. H. Mapping of the Alz 50 epitope in microtubule-associated proteins tau. J Neurosci Res. 1990 Mar;25(3):412–419. doi: 10.1002/jnr.490250319. [DOI] [PubMed] [Google Scholar]
  19. Lippa C. F., Smith T. W., Fontneau N. Corticonigral degeneration with neuronal achromasia. A clinicopathologic study of two cases. J Neurol Sci. 1990 Sep;98(2-3):301–310. doi: 10.1016/0022-510x(90)90271-n. [DOI] [PubMed] [Google Scholar]
  20. Mori H., Nishimura M., Namba Y., Oda M. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol. 1994;88(2):113–121. doi: 10.1007/BF00294503. [DOI] [PubMed] [Google Scholar]
  21. Motoi M., Yoshino T., Hayashi K., Nose S., Horie Y., Ogawa K. Immunohistochemical studies on human brain tumors using anti-Leu 7 monoclonal antibody in paraffin-embedded specimens. Acta Neuropathol. 1985;66(1):75–77. doi: 10.1007/BF00698299. [DOI] [PubMed] [Google Scholar]
  22. Murayama S., Arima K., Nakazato Y., Satoh J., Oda M., Inose T. Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 2. Oligodendroglial cytoplasmic inclusions. Acta Neuropathol. 1992;84(1):32–38. doi: 10.1007/BF00427212. [DOI] [PubMed] [Google Scholar]
  23. Murayama S., Mori H., Ihara Y., Tomonaga M. Immunocytochemical and ultrastructural studies of Pick's disease. Ann Neurol. 1990 Apr;27(4):394–405. doi: 10.1002/ana.410270407. [DOI] [PubMed] [Google Scholar]
  24. Nakano I., Iwatsubo T., Otsuka N., Kamei M., Matsumura K., Mannen T. Paired helical filaments in astrocytes: electron microscopy and immunohistochemistry in a case of atypical Alzheimer's disease. Acta Neuropathol. 1992;83(3):228–232. doi: 10.1007/BF00296783. [DOI] [PubMed] [Google Scholar]
  25. Nishimura M., Namba Y., Ikeda K., Oda M. Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci Lett. 1992 Aug 31;143(1-2):35–38. doi: 10.1016/0304-3940(92)90227-x. [DOI] [PubMed] [Google Scholar]
  26. Nishiyama E., Ohwada J., Iwamoto N., Arai H. Selective loss of calbindin D28K-immunoreactive neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study. Neurosci Lett. 1993 Dec 12;163(2):223–226. doi: 10.1016/0304-3940(93)90388-2. [DOI] [PubMed] [Google Scholar]
  27. Norenberg M. D. Astrocyte responses to CNS injury. J Neuropathol Exp Neurol. 1994 May;53(3):213–220. doi: 10.1097/00005072-199405000-00001. [DOI] [PubMed] [Google Scholar]
  28. Papp M. I., Kahn J. E., Lantos P. L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989 Dec;94(1-3):79–100. doi: 10.1016/0022-510x(89)90219-0. [DOI] [PubMed] [Google Scholar]
  29. Paulus W., Selim M. Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol. 1990;81(1):89–94. doi: 10.1007/BF00662643. [DOI] [PubMed] [Google Scholar]
  30. Probst A., Langui D., Lautenschlager C., Ulrich J., Brion J. P., Anderton B. H. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol. 1988;77(1):61–68. doi: 10.1007/BF00688244. [DOI] [PubMed] [Google Scholar]
  31. Rebeiz J. J., Kolodny E. H., Richardson E. P., Jr Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968 Jan;18(1):20–33. doi: 10.1001/archneur.1968.00470310034003. [DOI] [PubMed] [Google Scholar]
  32. Rebeiz J. J., Kolodny E. H., Richardson E. P., Jr Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc. 1967;92:23–26. [PubMed] [Google Scholar]
  33. Riley D. E., Lang A. E., Lewis A., Resch L., Ashby P., Hornykiewicz O., Black S. Cortical-basal ganglionic degeneration. Neurology. 1990 Aug;40(8):1203–1212. doi: 10.1212/wnl.40.8.1203. [DOI] [PubMed] [Google Scholar]
  34. Smith T. W., Lippa C. F., de Girolami U. Immunocytochemical study of ballooned neurons in cortical degeneration with neuronal achromasia. Clin Neuropathol. 1992 Jan-Feb;11(1):28–35. [PubMed] [Google Scholar]
  35. Smyrk T. C. Colon cancer connections. Cancer syndrome meets molecular biology meets histopathology. Am J Pathol. 1994 Jul;145(1):1–6. [PMC free article] [PubMed] [Google Scholar]
  36. Takemura R., Kanai Y., Hirokawa N. In situ localization of tau mRNA in developing rat brain. Neuroscience. 1991;44(2):393–407. doi: 10.1016/0306-4522(91)90064-u. [DOI] [PubMed] [Google Scholar]
  37. Tucker R. P., Garner C. C., Matus A. In situ localization of microtubule-associated protein mRNA in the developing and adult rat brain. Neuron. 1989 Mar;2(3):1245–1256. doi: 10.1016/0896-6273(89)90309-7. [DOI] [PubMed] [Google Scholar]
  38. Wakabayashi K., Oyanagi K., Makifuchi T., Ikuta F., Homma A., Homma Y., Horikawa Y., Tokiguchi S. Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations. Acta Neuropathol. 1994;87(6):545–553. doi: 10.1007/BF00293314. [DOI] [PubMed] [Google Scholar]
  39. Wolozin B. L., Pruchnicki A., Dickson D. W., Davies P. A neuronal antigen in the brains of Alzheimer patients. Science. 1986 May 2;232(4750):648–650. doi: 10.1126/science.3083509. [DOI] [PubMed] [Google Scholar]
  40. Yamada T., Calne D. B., Akiyama H., McGeer E. G., McGeer P. L. Further observations on Tau-positive glia in the brains with progressive supranuclear palsy. Acta Neuropathol. 1993;85(3):308–315. doi: 10.1007/BF00227727. [DOI] [PubMed] [Google Scholar]
  41. Yamada T., McGeer P. L., Baimbridge K. G., McGeer E. G. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 1990 Sep 3;526(2):303–307. doi: 10.1016/0006-8993(90)91236-a. [DOI] [PubMed] [Google Scholar]
  42. Yamada T., McGeer P. L., McGeer E. G. Appearance of paired nucleated, Tau-positive glia in patients with progressive supranuclear palsy brain tissue. Neurosci Lett. 1992 Jan 20;135(1):99–102. doi: 10.1016/0304-3940(92)90145-w. [DOI] [PubMed] [Google Scholar]
  43. Yamada T., McGeer P. L. Oligodendroglial microtubular masses: an abnormality observed in some human neurodegenerative diseases. Neurosci Lett. 1990 Dec 11;120(2):163–166. doi: 10.1016/0304-3940(90)90028-8. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES